Lancet
-
Meta Analysis
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
We aimed to investigate whether the benefits of blood pressure-lowering drugs are proportional to baseline cardiovascular risk, to establish whether absolute risk could be used to inform treatment decisions for blood pressure-lowering therapy, as is recommended for lipid-lowering therapy. ⋯ None.